Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Shorter-Course Levofloxacin Therapy Suitable for Serious UTI
Link ID 3696
Title Shorter-Course Levofloxacin Therapy Suitable for Serious UTI
Url http://www.medscape.com/viewarticle/570890?src=rss
Description A 5-day course of levofloxacin is at least as effective as a 10-day course of ciprofloxacin for treating acute pyelonephritis and complicated urinary tract infections (UTIs), note researchers from Ortho-McNeil Pharmaceuticals, which markets levofloxacin in the US as Levaquin. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date Mar 1, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Triglycerides and Insulin Resistance
  How does insulin resistance affect triglycerides?
Medscape Family Medicine
Category:   Articles > Pharmacists


2. Efficacy and Safety of TNF Inhibitors in the Treatment of Rheumatoid Arthritis
  Dr. Cohen reviews the latest data on the efficacy and safety of TNF inhibitors in the treatment of RA -- an update from ACR 2007.
Medscape Rheumatology
Category:   Articles > Pharmacists


3. Pyridoxine Metabolite Does Not Improve CABG Outcomes
  Treatment with MC-1, a naturally occurring pyridoxine metabolite, does not reduce nonfatal MIs or cardiovascular deaths in intermediate- to high-risk patients undergoing coronary artery bypass grafting (CABG), the results of a randomized trial indicate. Reuters Health Information
Category:   Articles > Pharmacists


4. Reduced-Toxicity Conditioning Increases Success of Stem Cell Transplant
  Reduced-toxicity conditioning can improve the outcomes of allogeneic hematopoietic cell transplantation candidates with advanced hematologic malignancies and older patients with more comorbidities, according to German researchers. Reuters Health Information
Category:   Articles > Pharmacists


5. Etanercept Appears Effective, Well Tolerated for Giant Cell Arteritis
  Etanercept may potentially replace corticosteroid therapy for patients with giant cell arteritis (GCA) who are experiencing adverse effects from the corticosteroid, according to the first randomized, double-blind, placebo-controlled trial of etanercept in patients with GCA. Reuters Health Information
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS